Catalyst Wire Dossier Catalyst Wire Dossier

ExPEC9V

9-valent ExPEC vaccine · Janssen Research & Development, LLC
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ExPEC9V, covering 2025-12-05 to 2026-06-05. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Vaccination With 9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) in the Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease in Adults Aged 60 Years And Older With a History of Urinary Tract Infection in the Past 2 Years [Phase 3]

See pricing